Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp (DH) provides actionable healthcare commercial data through its SaaS platform, empowering strategic decisions across the $4 trillion U.S. healthcare sector. This news hub delivers verified updates about DH's operational developments, financial milestones, and market leadership.
Key resources include: Earnings call summaries, product enhancement announcements, executive leadership changes, and partnership disclosures. Investors gain insights into recurring revenue trends while healthcare professionals track innovations in provider analytics and predictive modeling tools.
All content undergoes strict editorial review using primary sources including SEC filings and official company communications. Bookmark this page for real-time updates on DH's expanding data ecosystem covering 2.7M+ healthcare providers and 10K+ technology installations.
Definitive Healthcare announces a significant change in its Board of Directors, with Sastry Chilukuri joining as a member on September 30, 2022, while Randy Winn departs. Chilukuri, co-CEO of Medidata, brings over 22 years of experience in healthcare technology, expected to enhance the company's leadership in the life sciences sector. CEO Robert Musslewhite expressed optimism about Chilukuri’s contributions. Winn played a vital role in expanding the client base to over 3,000 and supporting the company through its recent IPO.
Definitive Healthcare Corp. (Nasdaq: DH) announced participation in two key conferences: the 2022 Baird Global Healthcare Conference in New York and the Goldman Sachs Communacopia + Technology Conference in San Francisco. CEO Robert Musslewhite will present on September 13, 2022, at 12:15 PM ET, while Executive Chairman Jason Krantz and CFO Rick Booth will present on September 14, 2022, at 5:15 PM PT (8:15 PM ET). Both presentations will be webcasted live, and replays will be accessible for a limited time on the investor relations website.
Definitive Healthcare (Nasdaq: DH) reported a 37% year-over-year revenue growth in Q2 2022, reaching $54.5 million. The net loss improved to ($9.6) million, representing 18% of revenue, compared to 38% in the previous year. Adjusted net income rose to $8.9 million, with an adjusted EBITDA of $16.3 million, or 30% of revenue. Cash flow from operations stood at $15.5 million or 28% of revenue. For Q3 2022, the company expects revenue between $56.0 – $57.0 million.
Definitive Healthcare Corp. (Nasdaq: DH) announced that its leadership team will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 9:30 a.m. Eastern Time. The presentation, featuring Founder Jason Krantz, CEO Robert Musslewhite, and CFO Rick Booth, aims to highlight the company’s innovations in healthcare commercial intelligence. A live webcast will be available on the investor relations website, with a replay accessible for a limited time.
Definitive Healthcare specializes in transforming data into insights for clients navigating the healthcare market.
Definitive Healthcare (Nasdaq: DH) has launched Passport Express, integrating analytical data from Analytical Wizards with extensive therapy-specific data. This new product enhances biopharma pre-launch planning across 20 therapy areas, providing vital commercial intelligence to accelerate market performance.
Passport Express offers ready-to-use analytics with up to seven interactive dashboards focused on market and brand dynamics, treatment pathways, and patient compliance. The aim is to simplify data sourcing for biopharma companies, ensuring up-to-date information is readily accessible.
Definitive Healthcare Corp. (Nasdaq: DH) will release its second quarter financial results for the period ending June 30, 2022, on August 4, 2022, after market close. A conference call will be held at 5:00 PM ET to discuss these results, which can be accessed via a live audio webcast on the company's Investor Relations website. A replay of the call will be available until August 18, 2022. Definitive Healthcare is known for transforming data into healthcare commercial intelligence, helping clients navigate market opportunities.
Definitive Healthcare (Nasdaq: DH) has launched Monocl ExpertInsight 2.0 and its mobile app Monocl ExpertGO, revolutionizing expert identification in healthcare. This platform grants medical affairs teams access to nearly 13 million expert profiles globally, enhancing productivity and streamlining workflows. Key features include live filters, advanced search options, and KOL mapping. Brazilian healthcare data has also been added to the platform. Existing customers can access these tools at no extra cost, aimed at accelerating drug and device market readiness.
Definitive Healthcare Corp. (Nasdaq: DH) will present at the Stifel 2022 Cross Sector Insight Conference. The session is scheduled for June 7, 2022, at 1:15 p.m. Eastern Time, featuring CEO Jason Krantz, CFO Rick Booth, and President Robert Musslewhite. Interested parties can access a live webcast on Definitive Healthcare's investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, using data and analytics to help clients succeed in the healthcare market.
Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference. The presentation is scheduled for May 23, 2022, at 9:20 a.m. Eastern Time. A live webcast will be accessible through their investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, providing clients insights to drive success in the healthcare market.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
